PAR 2.13% 23.0¢ paradigm biopharmaceuticals limited..

Pentosan polysulfate sodium promotes redifferentiation to the...

  1. 209 Posts.
    lightbulb Created with Sketch. 28
    Pentosan polysulfate sodium promotes redifferentiation to the original phenotype in micromass-cultured canine articular chondrocytes and exerts molecular weight-dependent effects

    https://pubmed.ncbi.nlm.nih.gov/37150611/

    advpub_22-0567.pdf

    by The Japanese Society of Veterinary Science / March 2023
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
-0.005(2.13%)
Mkt cap ! $80.45M
Open High Low Value Volume
23.5¢ 24.0¢ 23.0¢ $63.43K 270.4K

Buyers (Bids)

No. Vol. Price($)
10 213534 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 76890 2
View Market Depth
Last trade - 16.10pm 05/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.